TREATMENT OF HIGH-GRADE NON-HODGKINS-LYMPHOMAS WITH SHORT INTENSIVE CHEMOTHERAPY (MACOP-B)

被引：0

作者：

DELMER, A ^{[1
]}

BAUDUER, F ^{[1
]}

RUSKONEFOURMESTRAUX, A ^{[1
]}

AJCHENBAUMCYMBALISTA, F ^{[1
]}

DELMASMARSALET, B ^{[1
]}

RIO, B ^{[1
]}

MARIE, JP ^{[1
]}

ZITTOUN, R ^{[1
]}

机构：

[1] HOP HOTEL DIEU,SERV GASTROENTEROL,F-75181 PARIS 04,FRANCE

来源：

BULLETIN DU CANCER | 1993年 / 80卷 / 09期

关键词：

NON-HODGKINS LYMPHOMA; LARGE CELL; CHEMOTHERAPY; TOXICITY;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We present our results of a MACOP-B regimen in a series of 46 patients with high-grade NHL. The complete remission rate was 74%for patients with advanced stage disease. The excellent tolerance allowed this regimen to be given on an outpatient basis in the majority of cases. The median follow-up for the living patients is 28 months. Although some patients received additional treatment that could influence the results, the predicted DFS (disease-free survival) at 45 months of 57% compares favorably with the best results published so far with more toxic regimens.

引用

页码：808 / 815

页数：8

共 50 条

[41] LACTATE-DEHYDROGENASE LEVELS DURING MACOP-B CHEMOTHERAPY FOR NON-HODGKINS-LYMPHOMA
MCADAM, B
SMITH, T
LOVE, WC
MURPHY, M
DALY, PA
MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY, 1993, 10 (03): : 95 - 101
[42] TREATMENT OF LARGE-CELL NON-HODGKINS-LYMPHOMA WITH THE MACOP-B PROTOCOL
MONTALBAN, C
GARCIA, JLR
ROBLES, JM
SERRANO, M
ARECHAGA, S
PERALES, J
BELLAS, C
MEDICINA CLINICA, 1991, 97 (14): : 521 - 525
[43] MACOP-B CHEMOTHERAPY FOR THE TREATMENT OF AGGRESSIVE NONHODGKINS LYMPHOMA
MOUKADDEM, W
AOUDJHANE, M
ISNARD, F
STACHOWIAK, J
LAPORTE, JP
FOUILLARD, L
GORIN, NC
NAJMAN, A
LEUKEMIA & LYMPHOMA, 1992, 6 (4-5) : 357 - 361
[44] SHORT INTENSIVE CHEMOTHERAPY (COPE COMP) FOR INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA
CARTWRIGHT, KD
ARTHUR, CK
MA, DDF
ISBISTER, JP
BLOOD, 1993, 82 (10) : A561 - A561
[45] CYTOMORPHOLOGICAL AND IMMUNOCYTOCHEMICAL EVALUATION OF FINE NEEDLE ASPIRATES FROM HIGH-GRADE NON-HODGKINS-LYMPHOMAS
SCHMITT, FC
MAEDA, SA
HOKAMA, NK
MACHADO, PE
NIEROMELO, L
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1992, 25 (07) : 691 - 696
[46] ALTERED EXPRESSION OF THE RETINOBLASTOMA GENE-PRODUCT IN HUMAN HIGH-GRADE NON-HODGKINS-LYMPHOMAS
WEIDE, R
TIEMANN, M
PFLUGER, KH
KOPPLER, H
PARVIZL, B
WACKER, HH
KREIPE, HH
HAVEMANN, K
PARWARESCH, MR
LEUKEMIA, 1994, 8 (01) : 97 - 101
[47] SURVIVAL FOLLOWING COMBINATION CHEMOTHERAPY IN ADVANCED HIGH-GRADE NON-HODGKINS-LYMPHOMAS - RELATION TO PROLIFERATIVE ACTIVITY OF THE LYMPHOMA-CELLS
BRANDT, L
OLSSON, H
EUROPEAN JOURNAL OF HAEMATOLOGY, 1987, 38 (05) : 437 - 441
[48] LONG-TERM FOLLOW-UP OF PATIENTS RECEIVING SALVAGE CHEMOTHERAPY FOR INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMAS
LIANG, RHS
CHIU, EKW
CHAN, TK
TODD, D
NG, RP
HO, FFC
LOKE, SL
HEMATOLOGICAL ONCOLOGY, 1990, 8 (03) : 133 - 140
[49] TREATMENT OF ADULT NON-HODGKINS-LYMPHOMAS
GOBBI, PG
CAVALLI, C
HAEMATOLOGICA, 1986, 71 (04) : 321 - 343
[50] RANDOMIZED COMPARISON OF MACOP-B WITH CHOP IN PATIENTS WITH INTERMEDIATE-GRADE NON-HODGKINS-LYMPHOMA
COOPER, IA
WOLF, MM
ROBERTSON, TI
FOX, RM
MATTHEWS, JP
STONE, JM
DING, JC
DART, G
MATTHEWS, J
FIRKIN, FC
LOWENTHAL, RM
IRONSIDE, P
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) : 769 - 778

← 1 2 3 4 5 →